Speculative theory
Amygdalin B17Atlas
Health & Medicine · Suppressed treatments & alternative medicine
Amygdalin is commonly referred to as vitamin B17 and as laetrile in commercial, alternative-health, and medical commentary. Some product and advocacy materials present amygdalin or vitamin B17 as having antitumor or anticancer relevance.
Open the caseEvidence
12 cited sources · both-sides readings on each item
Laetrile (amygdalin or vitamin B17)
cancerresearchuk.org · secondary
- Pos A · Cancer Research UK materials are read as treating Amygdalin B17 claims as overstated versus the compared public record, citing not enough reliable evidence that it works.“There is not enough reliable evidence that it works”
- Pos B · Cancer Research UK materials are read as documenting continued promotion of Amygdalin B17 outside mainstream care, which affirming views treat as under-accounted for until research fills the shell.“Laetrile is promoted as an alternative cancer treatment”
B17 Amygdalin 100 Mg, 100 Capsules, by Apricot Power
nhc.com · secondary
- Pos A · Skeptical readings treat this retail listing as a commercial claim that frames amygdalin as routine immune support; it is cited as overstated relative to the compared public record until research supplies fuller sources for the shell.“essential B-17 for support of the immune system”
- Pos B · Affirming readings treat this retail listing as a public material that frames amygdalin as available immune-related support; it is cited as under-accounted for in mainstream summaries until research supplies fuller sources for the shell.“essential B-17 for support of the immune system”
Amygdalin – B17
verbraucherzentrale.de · secondary
- Pos A · Skeptical readings treat this consumer-protection page as aligning with conventional summaries: amygdalin’s anticancer effect is cited as not demonstrated, while cyanide formed on intake is read as a documented acute-poisoning hazard that research must still source carefully before the shell is settled.“Die Wirkung ist nicht nachgewiesen”
- Pos B · Affirming readings treat the same advisory as a mainstream caution that under-weights broader B17 claim sets in public materials; the undemonstrated-effect line is read as incomplete relative to affirming sources research must still supply before the shell is settled.“Amygdalin aus Aprikosenkernen gegen Krebs”
GoDaddy Security - Access Denied
tjsupply.com · secondary
- Pos A · The sales page is read as retail promotion of an amygdalin cream with GMP and purity claims; skeptical positions treat such materials as overstated relative to the compared public record pending further sources.“Order Vitamin B17 at: 800-811-3965”
- Pos B · The sales page is read as evidence of formulated amygdalin products with stated composition and manufacturer continuity; affirming positions treat such materials as under-accounted for in mainstream summaries pending further sources.“purified amygdalin is blended into a natural cream base”
B17 Amygdalin 100 Mg, 100 Capsules, by Apricot Power
nhc.com · secondary
- Pos A · Skeptical readings treat this retail listing as a commercial claim that amygdalin B17 supports immunity, cited as marketing copy rather than a settled clinical record; the shell is still read as needing fuller sourced comparison before any stronger conventional conclusion is drawn.“essential B-17 for support of the immune system”
- Pos B · Affirming readings treat this retail listing as public material presenting amygdalin B17 as essential immune support from apricot seeds, cited as under-reflected in mainstream summaries; the shell is still read as needing fuller sourced comparison before any stronger affirming conclusion is drawn.“essential B-17 for support of the immune system”
"The Ultimate Cancer Conspiracy - Vitamin B17/Laetrile (Amygdalin)" by Joe Vialls
healingcancernaturally.com · secondary
- Pos A · Conventional readings treat this page as advocacy material that presents Amygdalin B17 as overstated relative to the compared public record; the excerpt is read as asserting Krebs isolated B17 and broad cancer control, so the shell stays unsettled until further sources are supplied.“isolated a new vitamin that he numbered B17”
- Pos B · Affirming readings treat this page as documentary material that presents Amygdalin B17 as under-accounted for in mainstream summaries; the excerpt is cited as recounting Krebs isolated B17 and broad cancer control, so the shell stays unsettled until further sources are supplied.“found the complete control for all cancers”
shutterstock.com
shutterstock.com · secondary
- Pos A · Stock imagery is read as presenting amygdalin under the vitamin B17 label, which skeptical readings treat as an overstated designation relative to conventional public classifications pending fuller source review.“Molecular model of vitamin B17, amygdalin”
- Pos B · Stock imagery is cited as presenting amygdalin under the vitamin B17 label, which affirming readings treat as an under-accounted designation relative to mainstream public summaries pending fuller source review.“Molecular model of vitamin B17, amygdalin”
Amygdalin (Vitamin B17) | CancerNetwork
cancernetwork.com · secondary
- Pos A · Skeptical readings cite this oncology summary as treating Amygdalin B17 claims as unproved relative to clinical research, and as cautioning that unconventional agents may delay needed care.“No solid data supports its effectiveness”
- Pos B · Affirming readings cite this oncology summary as reflecting mainstream framing that under-accounts for Amygdalin B17’s sustained public use, and as requiring broader sources before the claim set is settled.“alternative cures are unproved and may be harmful”
Laetrile (Vitamin B17 or Amygdalin): Benefits, Myths and Food Sources
healthline.com · secondary
- Pos A · Public materials such as this Healthline page are read as placing Amygdalin B17 beside myths language and conventional caution, treated as signaling that stronger therapeutic claims remain overstated relative to the compared public record until fuller sourcing is supplied.“Benefits, Myths and Food Sources”
- Pos B · Public materials such as this Healthline page are read as still listing benefits and food sources for Amygdalin B17, treated as signaling that affirming accounts remain under-accounted for in mainstream summaries until fuller sourcing is supplied.“Benefits, Myths and Food Sources”
Amygdalin (Vitamin B17) - Amerigo Scientific
amerigoscientific.com · secondary
- Pos A · Skeptical readings treat the distributor listing as citing amygdalin under a 'Vitamin B17' label in commerce, read as overstated relative to conventional public-record framing until research supplies fuller sources.“Amygdalin (Vitamin B17) - Amerigo Scientific”
- Pos B · Affirming readings treat the distributor listing as citing amygdalin under a 'Vitamin B17' label in commerce, read as under-accounted for within mainstream summary framing until research supplies fuller sources.“provides high quality Amygdalin (Vitamin B17)”
Vitamin B17, amygdalin, laetrile and safety, benefits, dosage and side effects - VitaLibrary
vitalibrary.com · secondary
- Pos A · Public materials such as this VitaLibrary page are read as treating Amygdalin B17 claims as overstated relative to the record, with human benefits cited as unproven and cyanide release treated as central to safety limits.“human benefits remain unproven”
- Pos B · Public materials such as this VitaLibrary page are read as still leaving room that Amygdalin B17 is under-accounted for in mainstream summaries, with lab activity cited and full affirming sources treated as still required before settlement.“Lab research suggests possible anti-inflammatory and antioxidant activity”
Amygdalin A Nascent Vitamin B17 A Review.pdf
ijprajournal.com · secondary
- Pos A · Materials are read as framing amygdalin claims against limited human trials and FDA non-approval for safety; preclinical promise is treated as requiring conclusive clinical research before settled use.“human trials are limited, and the FDA has not approved”
- Pos B · Materials are read as framing amygdalin with promising preclinical anticancer findings and historical case series; mainstream limits are treated as leaving affirming accounts under-accounted pending further clinical sources.“While preclinical studies are promising, further research is needed”